Impact of circulating microRNA test (miRNA-371a-3p) on appropriateness of treatment and cost outcomes in patients with Stage I non-seminomatous germ cell tumours

Aditya Bagrodia*, Anna Savelyeva, John T. Lafin, Ryan W. Speir, Gregory T. Chesnut, Anne Lindsay Frazier, Solomon L. Woldu, Vitaly Margulis, Matthew J. Murray, James F. Amatruda, Yair Lotan*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Impact of circulating microRNA test (miRNA-371a-3p) on appropriateness of treatment and cost outcomes in patients with Stage I non-seminomatous germ cell tumours'. Together they form a unique fingerprint.

Medicine & Life Sciences